NewLead Holdings Ltd (NASDAQ:NEWL) dropped off Thursday after shares of the shipping company had soared for three consecutive days. The company announced on Monday it had received deliver of NewLead Holdings Ltd (NASDAQ:NEWL) Albion, an eco-type handysize vessel with a capacity of 32,318 dwt. Shares promptly exploded 305.2% on Monday and continued to rise Tuesdya and Wednesday in the wake of the news. The company also said it expects NewLead Holdings Ltd (NASDAQ:NEWL) Albion to generate $2 million EBITDA per year assuming $1.73 million yearly OPEX. Company agreed to purchase two eco-type vessels in March and paid $18.5 million for Albion. The second vessel is scheduled for delivery in July. NewLead Holdings Ltd (NASDAQ:NEWL) stock performance was -20.23% in last session and finished the day at $3.51. Traded volume was 13.37million shares in the last session and the average volume of the stock remained 2.57million shares. The beta of the stock remained 2.29. NewLead Holdings Ltd (NASDAQ:NEWL) insider ownership is 6.59%.

Isis Pharmaceuticals Inc (NASDAQ:ISIS) said its experimental blood thinner was more effective than an approved drug in patients undergoing total knee replacement surgery. Patients treated with a 300 mg dose of the drug, ISIS Pharmaceuticals Inc (NASDAQ:ISIS)-FXIRx, experienced a significantly lower incidence of blood clots in their veins, compared to patients given the approved drug, enoxaparin, Isis said. ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) rose 7.54 percent to $24.95 Thursday on volume of 4.23million shares. The intra-day range of the stock was $23.62 to $26.17. ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) has a market capitalization of $2.93billion.

YY Inc (ADR) (NASDAQ:YY)’s stock may be undervalued because U.S. investors don’t fully recognize the opportunity in the Chinese online music market, according to Maxim Group LLC Analyst Echo He. She says Chinese online music is a newer, growing market that is both scalable and profitable. Further, she says company is a leader in the market, creating an opportunity for investors. YY Inc (ADR) (NASDAQ:YY)’s stock on May 22, 2014 reported a increase of 11.12% to the closing price of $62.23. Its fifty two weeks range is $23.06 -$90.93. The total market capitalization recorded $3.65billion. The overall volume in the last trading session was 4.48million shares. In its share capital, YY has 55.71million outstanding shares.

Galena Biopharma Inc (NASDAQ:GALE) announced that data from the Company’s Phase 1 study with GALE-301, or Folate Binding Protein, will be presented at the upcoming American Society of Clinical Oncology (ASCO) 50th Annual Meeting. On Thursday, shares of Galena Biopharma Inc (NASDAQ:GALE) advanced 3.85% to close the day at $2.16. Company return on investment (ROI) is -225.80% and its monthly performance is recorded as -5.68%. Galena Biopharma Inc (NASDAQ:GALE) quarterly revenue growth is -44.76%.